Clinical trial Recruiting at 3 sites Observational Ages 6 and up

Longitudinal study on cardiovascular risk factors in Swiss municipalities

Official title: Swiss Longitudinal Cohort

Run by Hypertension Excellence Centre Lucerne · NCT02282748 · Data updated 2026-11-12

This study looks at heart health and risk factors in people from three Swiss towns to see how they change over time.

Quick facts

Study typeObservational
Ages6 Years and up
SexAll
Enrollment1000 (estimated)
SponsorHypertension Excellence Centre Lucerne
Academic / other
Locations3 sites (Uznach, Canton of St. Gallen and 2 other locations)
StatusRecruiting
StartedOctober 2014
Main results expectedSeptember 2024
Study endsSeptember 2034
Registry record updatedFebruary 18, 2020
Trial IDNCT02282748 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are residents of Cama GR, Lostallo GR, or Uznach SG, aged 6 years and older.

Probably not a fit

Patients who do not reside in the specified municipalities or are unwilling to participate in a long-term study may not benefit from this research.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research project is a prospective population-based cohort study aimed at examining cardiovascular risk factors in three Swiss municipalities. Recruitment began in 2014 in Lostallo/Cama and concluded in 2019, with a total of 496 participants. The study involves a five-year follow-up and plans to start recruitment in a second municipality, Uznach, in 2020. Participants undergo a variety of measurements to gather comprehensive data on cardiovascular health.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into cardiovascular risk factors specific to the Swiss population, potentially leading to improved prevention strategies.

How similar studies have gone: While this study is modeled after the well-known Framingham study, it represents a novel approach in Switzerland as there are no similar research projects currently underway.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Resident of Cama GR, Lostallo GR, or Uznach SG
* Age ≥6 years (no upper age limit), for voluntary blood sample ≥18 years
* Willing to participate in long-term study
* Written informed consent (in participants ≥6 years and \<18 years signed by parents)

Exclusion Criteria:

* No exclusion criteria

Where it's running

  • Linth Hospital
    Uznach, Canton of St. Gallen, Switzerland
    Recruiting
  • Cama
    Cama, Kanton Graubünden, Switzerland
    Recruiting
  • Lostallo
    Lostallo, Kanton Graubünden, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Andreas W Schoenenberger, MD — University Department of Geriatrics, University of Bern
  • Study coordinator: Paul Erne, MD
  • Email: paul.erne@erne-net.ch

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.